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Objectives: Age-related changes in articular cartilage are likely to play a role in the aetiology of oste-
oarthritis (OA). One of the major age-related changes in cartilage is the accumulation of advanced-
glycation-endproducts (AGEs). Since, cartilage tissue is not readily available from patients for studying
AGE levels, alternative approaches such as analyzing skin and urine are needed to study the role of
cartilage AGE levels in OA.
Methods: Paired human skin and cartilage samples were obtained post mortem. Paired skin and urine
samples were obtained from the CHECK cohort (early OA patients). Pentosidine levels were measured by
high-performance liquid chromatography (HPLC). As marker of cumulative cartilage damage X-rays of
both knees and hips were scored. Urinary CTXII (uCTXII) levels were measured, to assess current cartilage
breakdown.
Results: Cartilage and skin pentosidine correlate well (R¼ 0.473, P¼ 0.05). Skin pentosidine was higher in
mild (summed (Kellgren & Lawrence K&L) over four large joints 4) compared to no (summed K&L3)
radiographic OA (P¼ 0.007). Urinary pentosidine was not different between these two groups. Skin
pentosidine levels were not related to cartilage breakdown (highest vs lowest tertile of uCTXII). Urinary
pentosidine, however, was higher in the highest compared to the lowest uCTXII tertile (P¼ 0.009).
Multiple regression analysis showed age to be the only predictor of the summed K&L score and age,
creatinine clearance and urinary pentosidine as predictors of uCTXII.
Conclusion: The higher skin and urinary pentosidine levels in those with mild compared to no radio-
graphic joint damage and low vs high cartilage breakdown respectively suggest that AGEs may
contribute to disease susceptibility and/or progression. However, relations are weak and cannot be used
as surrogate markers of severity of OA.
 2010 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.Introduction
Osteoarthritis (OA) is the most common disease of the elderly,
witha large impacton theparticipants qualityof life1.With increasing
age, the prevalence of OA increases exponentially2. In addition to
chondrocyte senescence3, one of the major age-related changes in
articular cartilage is the modiﬁcation of proteins by non-enzymatic.P.J.G. Lafeber, Rheumatology
entre Utrecht, PO box 85500,
1; Fax: 31-30-2523741.
Lafeber).
s Research Society International. Pglycation (NEG). NEG is a common posttranslational modiﬁcation of
proteins causedby reducing sugars. The spontaneous condensationof
reducing sugarswith free amino groups in lysine or arginine residues
on proteins leads to the formation of a reversible Schiff base, which is
subsequently stabilized by Amadori rearrangement. Maillard reac-
tions subsequently convert the initially formed intermediate prod-
ucts into advanced-glycation-end products (AGEs)4. As such, NEG can
result in adducts to a protein, changing its properties5, but also in the
formation of cross-links between proteins, changing the integrity of
the cartilage matrix6. Modiﬁcation by lipids is possible as well,
producing advanced lipoxidation end products (ALEs)7. Moreover,
NEG may change proteins of other tissues that are involved in jointublished by Elsevier Ltd. All rights reserved.
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AGE accumulation is highest in cartilage due to its lowest turnover,
the impact of the changes are likelymost prominent in cartilage. This
is because once they are formed, AGEs are only removed from the
tissue when the protein involved is degraded. Articular cartilage
collagen and proteoglycan proteins have an exceptionally long half-
life in humans. Since the rate of AGE accumulation is largely deter-
mined by the rate of protein turnover9, this low turnover results in an
abundant accumulation of AGEs in articular cartilage with increasing
age6,10.
It has been reported that the accumulation of AGEs in cartilage
tissue leads to inferior mechanical properties6,11 and an alteration
in cartilage metabolism5,12. In vivo effects of AGEs have been
identiﬁed in a canine model of experimentally induced OA by
anterior cruciate ligament transection (ACLT). Animals with artiﬁ-
cially elevated AGE levels developed more progressive OA after
ACLT than did those with normal AGE levels13. Also, AGE levels in
the macroscopically normal cartilage of humans with focal OA was
signiﬁcantly higher than in control cartilage, suggesting that
elevated AGE levels predispose to OA development14.
To further understand the role of AGEs in OA, ideally cartilage
biopsies would be used to assess AGE levels and relate those to OA
development and/or progression in longitudinal clinical study
designs. The drawback of such approach is e amongst others e the
possibility of interfering with the disease process (the cartilage
biopsy may induce and/or accelerate OA development). Also the
effect of an ongoing disease process in which cartilage may have an
increased turnover, affects the AGE levels of the cartilage biopsies15.
An alternative and more feasible approach might be the use of the
AGE characteristics of another, more accessible, connective tissue
with relative low turnover, such as skin, as a surrogate for the AGE
characteristics of cartilage. AGEs accumulation with increasing age
in skin collagen is similar to that in cartilage9. Only once, the
relation between skin AGEs and OA has been studied. Skin ﬂuo-
rescence was measured by a skin auto ﬂuorescence reader of
participants with severe OA and of a control group. No statistically
signiﬁcant difference was found between these two groups. The
drawback of this study is that OA was in an advanced stage with
presumably cartilage repair activity accompanying cartilage
degeneration and the age of the participants was signiﬁcant
different between both groups16. Moreover, skin ﬂuorescence is
a rather rough measure for AGE accumulation.
Other surrogates for cartilage AGE levels include the analysis of
AGEs in more easily accessible body ﬂuids such as serum and urine.
AGE concentrations are signiﬁcantly higher in serum than in
synovial ﬂuid in participants with knee OA17. Irrespectively,
previous studies have demonstrated a relation between serum AGE
levels and OA. Serum pentosidine, being one of the characteristic
AGE products, was signiﬁcantly higher in participants with OA
compared to healthy controls17,18, however no correlation with
radiographic stage of the disease could be found. Baseline serum
pentosidine had a signiﬁcant relation to progression of OA, based
on joint space narrowing18. These results were never conﬁrmed by
other groups19.
Urinary pentosidine, on the other hand showed different results.
No signiﬁcant difference in urinary pentosidine levels were found
between participants with knee OA and controls20. Urinary pen-
tosidine levels could not predict cartilage loss (by MRI) in persons
with symptomatic knee OA21. The only relationship found with
urinary pentosidine was a signiﬁcant higher concentration before
compared to after joint replacement surgery20. Since urinary pen-
tosidine levels are determined by many of the same factors as
serum levels (i.e., intake, tissue degradation, and clearance), the
usefulness of urinary pentosidine levels as surrogate for cartilage
levels to relate to OA development might be debated.Because of the intriguing accumulation of AGEs with increasing
age and the strong relation between age and development of OA,
the absence of relevant knowledge on skin AGEs as a surrogate
marker for cartilage AGEs, the contradictory results for urine AGE
levels when compared to serum AGE levels as marker for OA
severity, and the absence of any AGE data in case of very early OA,
the present study describes the presence of AGE in skin and urine in
relation to OA severity, in a cohort of participants with very early
signs of knee and/or hip OA (CHECK).
Method
Paired skin and cartilage samples
At autopsy, paired cartilage and skin samples were obtained
from 17 donors within 24 h after death. Macroscopically normal
cartilage was obtained from femoral knee condyles and humeral
heads. Cartilage was cut into full-thickness samples weighing
5e15 mg. In the same procedure, full-thickness skin samples
(10e30 mg) were taken from the incision site. All samples were
stored at 20C. From these paired samples pentosidine, as
a marker of AGE, was measured.
Cohort description
Part of the participants included in CHECK (the Dutch ‘cohort hip
& cohort knee’) was asked to participate in the present study. From
the 10 institutes that included 1002 participants, three centers (300
participants) were asked to participate in the present study. Partic-
ipants were included with pain and/or stiffness in hip and/or knee,
aged 45e66 years, who never or no longer than 6 months before
inclusion had visited the general practitioner for these complaints.
Participants with a known rheumatic condition, pain in a joint
replaced by prosthesis, co-morbidity which reduces normal func-
tion,malignancy in the last 5 years, complaints started after trauma,
pain in a joint that has previously been under surgery and K&L grade
4 on hip and/or knee radiographwere excluded. The researchers did
not interfere with usual care with respect to advice, diagnostics nor
treatment. For details seeWesseling et al.22. The studywas approved
by the medical ethical committees all participating centers.
Skin samples
All 300 participants were asked to give approval for a full-
thickness punch skin biopsy (4 mm Ø). After written informed
consent the biopsy was taken from the lower back under lidocain
1% and 1/100000 adrenaline local anaesthetic. Skin samples were
immediately frozen in liquid nitrogen and stored at 80C.
Urine samples
At inclusion and 3 months later a urine sample was collected
and frozen at80C. Circadian variation of biomarker levels23 were
not taken into account, due to logistic constraints associated with
the CHECK cohort.
AGE measurement in skin, cartilage, and urine
Pentosidine was used as a measure of AGEs. Pentosidine in
the skin and cartilage were measured as described previously10.
Samples were reduced overnight, sequentially treated with
L-Cysteine (5 mM, Sigma), EDTA (50 mM, Sigma), NaOH (1 M,
Merck) and papain (3% v/v. Sigma).
Collagen pentosidine content and amino acid composition were
determined by high-performance liquid chromatography (HPLC).
Fig. 1. The correlation between cartilage and skin pentosidine. Paired cartilage and
skin samples were obtained post mortem of 17 donors. Cartilage was obtained from
femoral knee condyles and humeral heads, skin samples were taken from the incision
site. Regression coefﬁcient and p value have been provided.
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papain digest were dissolved in water containing the internal
standards pyridoxine (10 mM; Sigma) and homoarginine (2,4 mM;
Sigma). Samples were diluted four fold with 1% heptaﬂuorbutyric
acid in 10% acetonitril and analyzed by HPLC24. For amino acid
analysis, an aliquot of the crosslink samples was diluted 200-fold
with 0.1 M borate buffer (pH 11.4), derivatized with 9-ﬂuo-
renylmethyl chloroformate and analyzed by HPLC25. The pentosi-
dine content of collagen samples is expressed as mM/M collagen,
assuming 300 Hyp residues per triple-helical collagen molecule25.
A calibration curve (R2¼ 0.999) was used (0e12.5 pmol pentosi-
dine/ml). The %CV was on average 6.8% for the various pentosidine
concentrations within the calibration curve.
Urine pentosidine was measured by HPLC21 in diluted non-
hydrolysed urine (1:1 in 0.025% H2SO4) following injection of 50 ml
on a Whatman partisik 10 SCX column (250*4.6 mm). Pentosidine
was eluted using an isocratic gradient of 0,025% H2SO4 and 100 mM
Al2(SO4)3 in 0.025% H2SO4. Column temperature was kept 60C and
eluted pentosidine detected by a Jasdo FP-1520 ﬂuorimeter at
328 nm (ex) 378 nm (em). Puriﬁed pentosidine calibrated by mass
spectroscopy served as a reference. Urinary creatinine was deter-
mined using the Johnson & Johnson Vitos 250 Clinical Chemistry
Slides. Urinary pentosidine values were normalized by urinary
creatinine to account for urinary dilution.
Radiographic joint damage
X-rays of both knees and hips were performed in all partici-
pants, independent of symptoms and signs. Radiographs of tibio-
femoral (TF) joints were made by a weight-bearing (WB) posterior
anterior (PA) view, semi-ﬂexed (7e10) according to Buckland-
Wright26. For the hip, WB anterior posterior (AP) radiographs of the
pelvis were made27. For details see Wesseling et al.22.
Radiographs were scored according to Kellgren & Lawrence
(K&L)28. Total scores were calculated by taking the sum of the
individual scores of the four joints leading to a maximum score of
16. Although a K&L grade 3 in one joint may reﬂect a different
disease than K&L grade 1 in three joints a summed score is an
accepted way to present a general burden of OA. This general
burden might be related to the AGE load of a person as hypothe-
sized. Moreover, evaluation single joints are biased by inﬂuence of
explicit secondary OA in single joints, whereas the sum (or average)
of the four larger joints means this potential variation and repre-
sents the more general OA burden.
Additionally, knee X-rays were evaluated by Knee Images Digital
Analysis (KIDA)29 and hip X-rays by Holy (Holy’s software-b19/
20)30. These are computer assisted programs that semi-auto-
matically calculates, mean and minimum joint space width (JSW).
The sum of the minimum, mean (lateral and medial compartment),
and smallest mean (lateral or medial compartment) JSW of four
joints was used for further analysis. In total 22 X-rays were
excluded due to technical problems (inferior X-ray quality did not
allow KIDA analysis). MTP alignment was used for all knee X-rays.
Cartilage breakdown; urinary CTXII (uCTXII)
CTXII as a biomarker speciﬁc for degradation/turnover of hyaline
cartilage type II collagen was measured by ELISA (CartiLaps, Nordic
Bioscience, Herlev, Denmark). Intra-assay and inter-assay variation
of the same sample were less than 9% and 11%, respectively.
Kidney function
As a potential confounder, kidney functionwas determined. Creat-
inine in peripheral blood was measured by Unicel DxC 800, BeckmanCoulter (Fullerton, Ca, USA). Estimated glomerular ﬁltration rare was
calculated by the Cockroft-Gault formula (creatinine clearance¼[(140-
age)*weight/](0.84*serum creatinine)*0.85(if subject is female)).
Creatinine clearance is expressed in mm/min/1.73m2 31.
Statistical analysis
Since the measurements of pentosidine were not normally
distributed non-parametric statistical test were used. Differences
between groups of summed K&L (i.e., sum of K&L grade of the two
knees and hips) were ﬁrst described and tested by a non-para-
metric ManneWhitney U test. P-values< 0.05 were considered
statistically signiﬁcant.
Subsequently, non-parametric Spearman correlations were
calculated for the association betweenmeasures of pentosidine and
total joint damage (measured as the sum of K&L scores in all four
joints). Multiple regression analysis was used to describe the
association between the measures of pentosidine and joint damage
and to evaluate the inﬂuence of multiple participant characteristics
(confounders) in addition to pentosidine levels on total joint
damage. Subgroup analyses for the hips and the knees were per-
formed as well. SPSS 15.0 software was used.
Results
Skin vs cartilage pentosidine
Pentosidine as a marker for AGE levels was measured in post
mortem cartilage and skin samples of the same individuals.
A statistically signiﬁcant correlation was found between these 17
paired cartilage and skin pentosidine levels (R¼ 0.473, P¼ 0.05;
Fig. 1). Pentosidine levels were normalized to collagen amount and
a regression coefﬁcient of 0.19 for the association between skin and
cartilage pentosidine was found. This can be interpreted as an
increase in skin pentosidine per unit increase of cartilage pentosi-
dine of 0.19 points (i.e., as such might be concluded that the
accumulation of pentosidine is w5 times higher for cartilage than
for skin), consistent with previously unpaired data10.
Characteristics of the study population
Three hundred participants from the three different medical
centers were asked to participate in this study, 244 signed informed
consent. From these 244 participants complete data sets (skin and
urine pentosidine levels, age, BMI, creatinine clearance, and X-ray
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loss of participants was due to missing urine pentosidine data on
both time points (49). In 19 cases the only available single sample
was used. In Table I the characteristics of these 205 participants are
given. Note that although most participants fulﬁlled the ACR
criteria for clinical OA for at least one joint (65%) this is a cohort
with no to mild radiographic joint damage (68% and 26% K&L grade
0 and 1, respectively of the 820 joint radiographs). Mean JSW varied
between 1.61 and 8.43 mm for knee and 1.21 and 6.66 for hip.Skin pentosidine related to radiographic joint damage
Participants were divided in two groups based on radiographic
joint damage, participants with a summed K&L score of the four
joints 3 and 4, further indicates as ‘no’ and ‘mild’ radiographic
joint damage, respectively. In the group with mild radiographic
joint damage slightly (but statistically signiﬁcant) higher skin
pentosidine levels were found (Fig. 2(A)). Because cartilage volume
of the knee is larger than of the hip32, separate evaluations for knee
and hip were made. In these cases the cut-off for no and mild
radiographic damage was set on 1 and 2, respectively. For knee
OA a higher skin pentosidine level in the group with mild radio-
graphic joint damage was observed compared to the subjects
without OA. This difference was not found when participants were
grouped based on severity of hip OA (Fig. 2(B) and 2(C),
respectively).
Although in dichotomous categories there was a difference in
skin pentosidine for those participants with the summed K&L score
4 vs the group with a score of 3, using Spearman rank corre-
lation no correlations between skin pentosidine and summed K&L
scores were found. Only in case of the knee a tendency toward
a signiﬁcant correlation was observed (R¼ 0.122, P¼ 0.082;
Fig. 2(D)).
When joint space widths (minimal, mean and smallest mean)
were measured as continuous variable by use of digital analyses of
the radiographs (KIDA and Holy) no correlations were found
between skin pentosidine levels and the sum of the mean and
minimum JSW of the four joints, nor when knees and hips were
taken separately (data not shown).Table I
characteristics of the 205 participants included in the cohort. Variables are displayed
in mean SD (minimumemaximum) if applicable
Number of participants 205
Age (years) 55.5 5.4 (44e66)
Gender (male/female) 33/172
Skin pentosidine/collagen (mmol/mol) 2.42 0.79 (0.948e5.685)
Urine pentosidine/creatinine (mmol/mol) 0.57 0.18 (0.26e1.58)
CTXII (mg/mmol) 0.32 0.18 (0.03e0.99)
Creatinine clearance (cockroft-gault; ml/min) 93.4 21,5 (52,0e170)
BMI 26.8 3,8 (15,4e40,4)
Summed mean JSW of both knees (mm) 10.13 2.05 (4.51e16.26)
Summed minimum JSW of both knees (mm) 6.36 1.89 (0.03e10.26)
Summed mean JSW of both hips (mm) 8.16 1.40 (2.97e12.27)
Summed minimum JSW of both hips (mm) 7.13 1.41 (1.21e11.53)
Summed mean JSW of all four joints (mm) 18.43 2.82 (12.09e26.29)
Summed min JSW of all four joints (mm) 13.58 2.36 (6.96e18.80)
# of joints with OA according to
ACR clinical criteria
0 1 2 3 4 Missing At least
1 joint
Number of patients 56 57 66 6 5 15 134
Summed K&L grade of 4 joints 0 1 2 3 4 5 6 7 8
Number of patients 67 57 34 15 21 3 4 2 2
Dichotomous numbers 173 32Skin pentosidine related to cartilage breakdown
In case levels of CTXII (a biochemical marker of cartilage
breakdown)33 were used as an outcome parameter for cartilage
breakdown, no difference were found for skin pentosidine between
patients with different levels of uCTXII, analyzed as continues as
well as ordinal variable (data not shown).
Skin vs urine pentosidine
Because of diet-induced variation in urine NEG and with that
pentosidine levels, pentosidine in urine was measured twice, at
inclusion and after 3 months (mean difference of these two
measurements 17 nmol/mol; 95% conﬁdence interval 5.5 to
39.6 nmol/mol). The mean of these two AGE levels was used for
further calculations. There was a small but statistically signiﬁcant
correlation between skin and urinary pentosidine (R¼ 0.285,
P¼ 0.001; Fig. 3).
Urine pentosidine related to radiographic joint damage
No difference could be found for urine pentosidine between the
participants with no vs mild radiographic joint damage (data not
shown). Separate evaluations for knee and hip radiographic
damage did not provide a difference in urine pentosidine levels
between the groups (data not shown). No correlations between
urine pentosidine and summed K&L scores were found. When joint
space widths (minimal, mean, and smallest mean) were measured
digitally as continuous variables, no correlations were found with
urine pentosidine levels either (data not shown).
Urine pentosidine related to cartilage breakdown
Urine pentosidine levels on the other hand differ between
patients within the lowest tertile of uCTXII levels from those within
the middle and highest tertile CTXII levels (P¼ 0.033 and 0.009
respectively; Fig. 4(A)). Also a correlation was found between urine
pentosidine and CTXII a measure of cartilage breakdown (R¼ 0.235
P¼ 0.001; Fig. 4(B)).
Inﬂuence of other factors related to K&L
In addition to skin and urine pentosidine levels several partici-
pant/patient characteristics are known to inﬂuence K&L score or
uCTXII levels, including factors such as age, BMI and, gender. For
serum pentosidine it is known that age and creatinine clearance are
major inﬂuencing factors. Table II shows the results of the univar-
iate linear regression analyses with total joint damage as outcome
variable. A statistically signiﬁcant relation between creatinine
clearance, age, and gender and total joint damage was found, for all
other parameters no relationwas found. Inmultivariable regression
analysis (Table II) with skin pentosidine, mean urine pentosidine,
creatinine clearance, age, BMI, and gender as independent variables
and summed K&L as dependent variable the explained variance
was low (R2¼ 0.068) indicating that all parameters explain 6.8% of
the summed K&L score. The partial regression coefﬁcient for
creatinine clearance and age showed a tendency to statistically
signiﬁcant (P¼ 0.099 and 0.067 respectively).
In case of uCTXII as outcome parameter of cartilage breakdown
(Table II) with skin pentosidine, mean urine pentosidine, creatinine
clearance, age, BMI, and gender as independent variables the
explained variancewas intermediate (R2¼ 0.396) indicating that all
parameters explainw40% of the CTXII level. The partial regression
coefﬁcient for urine pentosidine level, age, and creatinine clearance
was statistically signiﬁcant. Multivariate analysis for skin and urine
Fig. 2. Correlation of skin pentosidine and the summed K&L score of the four joints. The summed K&L score was divided into two groups, no (summed K&L score 0e3; n¼ 173) and
mild (summed K&L score 4e12; n¼ 32) radiological OA. Joint with K&L score four were not included. Participants with low radiological OA had a lower skin pentosidine compared
to the participants with mild radiological OA (A). Separating the knees (B; summed K&L score 0e1 or 3e6; n¼ 178 and 27, respectively) and hips (C; summed K&L score 0e1 or 3e6;
n¼ 138 and 67, respectively) shows that only for the knees this difference is maintained. Median (dash), with the interquartile range (box; 50%) with the ﬁfth and nintyﬁfth
percentiles (whiskers) are presented. (D) The correlation between skin pentosidine and summed K&L score of the two knees (n¼ 205). Spearman correlation coefﬁcient with p value
has been provided.
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comparable results.Discussion
This is the ﬁrst study describing the relationship between skin
and urine pentosidine with severity of joint damage in early OA,
using radiographic OA and uCTXII as markers of cumulative carti-
lage damage and current breakdown, respectively. In this cross-
sectional study a small, but statistically signiﬁcant, increase in skin
pentosidine levels was observed in participants with mild vs no
radiographic joint damage. Urinary pentosidine was not correlatedFig. 3. The correlation between mean urine pentosidine and skin pentosidine of 205
participants. There is a statistically signiﬁcant correlation between both parameters,
with a low correlation coefﬁcient.with radiographic OA. For urine pentosidine levels a weak corre-
lation was found with cartilage breakdown as measured by uCTXII,
but not for skin pentosidine.
Skin and cartilage share several characteristics inﬂuencing AGE
formation. Tissue glucose concentration and oxidative stress are
relatively similar for cartilage and skin collagen10. Both cartilage
and skin collagen AGE formation are presumably dependent on
glucose levels and not on other sugars34. However, cartilage and
skin collagen have a different protein turnover rate. Cartilage
collagen does hardly renew during life35, whereas skin collagen
has a turnover faster than cartilage36. This was also clear from our
study; cartilage pentosidine is w5 times higher compared to skin
pentosidine levels in paired samples. This ﬁts well with the slow
turnover of collagen in cartilage compared to skin and conse-
quently a higher rate of AGE accumulation in cartilage compared to
skin. Using skin pentosidine levels as a surrogate of cartilage
pentosidine a weak but statistically signiﬁcant relation with
severity of radiographic OA was found. Assuming cartilage AGE
levels to be directly related to OA a stronger relation was expected.
However, the observed variance between cartilage and skin pen-
tosidine levels limits the usefulness of skin AGE levels as a repre-
sentative of cartilage AGE levels and as such hampers studies on
the causality of the relationship. Furthermore, in case of the
dichotomous division into ‘no’ vs ‘mild’ radiographic damage, age
was different between both groups for the total as well as for the
knee separately (P¼ 0.05 and 0.02 respectively). As such
the difference in skin pentosidine levels can also be explained by
the difference in age between both groups. This dominance of age
in pentosidine levels was also found in the multiple regression
analyses (Table II).
It should be noted that the use of X-rays in general and most
speciﬁcally in the present cohort with very early OA has its limi-
tations. The K&L score is a poor indicator of articular cartilage
damage, in the early phases of the disease. Also joint space nar-
rowing (JSN) in the knee may be inﬂuenced by many factors other
than cartilage damage including meniscus extrusion, subluxation,
poor alignment of the medial tibial plateau (resulting in suboptimal
measurements), hypertrophic cartilage repair (increasing the JSW),
Fig. 4. Correlation of mean urine pentosidine (A) and urine CTXII levels divided into three groups, low ( 0.22 mg/mmol; n¼ 65), middle (0.22e0.37 mg/mmol; n¼ 66) and high
(0.37 mg/mmol; n¼ 66) CTXII levels. For urine pentosidine all groups were different except the middle and high CTXII group. Median (dash), with the interquartile range (box; 50%)
with the ﬁfth and nintyﬁfth percentiles (whiskers) are presented. Fig. B shows the correlation between urine pentosidine and CTXII levels. A low correlation between these
parameters was found (R¼ 0.235, P¼ 0.001; n¼ 200).
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a potential relationship between cartilage composition (i.e., AGE
level) and OA.
In the present study, no differences in urinary pentosidine
between no and mild OA based on radiographic OA was found, an
outcome that corroborates other studies20,21. On the other hand,
urine pentosidine correlated with uCTXII as a marker of cartilage
breakdown. In multivariable regression analyses this was still
evident in addition to age and creatinine clearance, suggesting that
urinary pentosidine may more reﬂect current cartilage breakdown
than overall AGE level. Skin pentosidine did not correlate with
uCTXII. Since both the urinary pentosidine and the uCTXII are
excreted via the kidney, kidney function may limit variations due to
individual differences in processing and by that can explain that
this correlation was found for urinary pentosidine and not for skin
pentosidine.Table II
The regression of different parameters with summed K&L score in univariate regression an
with summed K&L score
Univariate analysis
Summed K&L
R p b p
Skin pentosidine/collagen 0.242 0.111 0.004 0.9
Mean urine pentosidine/creatinine 0.326 0.632 0.002 0.9
Creatinine clearance 0.013 0.015 0.144 0.0
Age (years) 0.064 0.003 0.148 0.0
BMI 0.021 0.506 0.027 0.7
Gender P¼ 0.019 0.110 0.1
The b coefﬁcients and p values for multivariate regression analysis with skin pentosidine
variables and summed K&L score and CTXII as outcome measurement are indicated.
Multivariate regression with only skin or urine pentosidine is included as well.The fact that skin pentosidine correlates with radiographic OA
and urine pentosidine does not might be explained by the fact that
skin pentosidine is a marker of the lifelong accumulation of AGEs in
tissue, similar to the accumulation of AGEs in cartilage tissue.
Urinary pentosidine is measured in a momentum (as is uCTXII)
dependent on various factors including peripheral turnover. In
general it should be noted that pentosidine is used as a biomarker
for the whole class of AGEs. Other AGEs such as carbox-
ymethyllysine could be similarly used for this purpose. It cannot be
excluded that other relations would have been found when other
markers would have been analyzed.
In general there are numerous confounding factors in ﬁnding
a relation between surrogate markers of cartilage AGE levels (skin
and urine pentosidine) and cartilage damage (JSW on X-ray and
urine CTXII). The complexity between cartilage, bone, synovial
tissue, ligaments and muscle strength all determine cartilagealysis. Age, creatinine clearance and gender showa statistically signiﬁcant regression
Multivariate analysis
CTXII Summed K&L CTXII
b p b p b p
58 0.010 0.894 0.004 0.955
82 0.211 0.003 0.210 0.003
99 0.241 0.004 0.144 0.098 0.242 0.004
67 0.269 0.001 0.149 0.062 0.265 0.000
47 0.002 0.979 0.027 0.747 0.002 0.979
25 0.070 0.307 0.110 0.115 0.071 0.297
, mean urine pentosidine, BMI, age, creatinine clearance, and gender as independent
P.A.J.M. Vos et al. / Osteoarthritis and Cartilage 18 (2010) 1329e1336 1335damage41 and are not directly related to cartilage AGE levels.
Moreover, AGEs by themselves do not cause OA, rather they
predispose to the development of the disease. A trigger, most likely
mechanical of nature, is needed to induce the disease process.
Accumulation of AGEs increase the susceptibility of articular
cartilage to damage due to micro-traumata over a lifetime6,8. In
other words, AGE accumulation makes the joint more prone to
develop diseases.
It has been demonstrated that nearly one-third of human knees
from donors in their seventheninth decade who had no history of
arthritis, showed no evidence of OA42. According to this hypothesis,
elderly without OA either have low AGE levels, or have high AGE
levels, but did never encounter a sufﬁciently strong mechanical
trigger that induced the disease. The latter however is difﬁcult to
verify.
In the present study we speciﬁcally choose for very early joint
degeneration. In more advanced stages breakdown of cartilage
might be accompanied by repair activity and breakdown of
repaired tissue, the latter with relative low levels of accumulated
AGEs. In these more advanced stages the complex turnover rate of
cartilagematrix might disturb a potentially clear correlation. This is
supported by the fact that Matsumoto and co-workers16 did not
ﬁnd enhanced skin AGE levels in advanced stage OA, whereas the
present study demonstrated this, although rather weak.
In conclusion, the current data support earlier observations that
urinary pentosidine levels are not of use as surrogate markers of
severity of cartilage breakdown in clinical studies, despite its
correlation with another marker of cartilage breakdown, CTXII.
However, our data show that skin pentosidine (which is unlikely to
be affected by tissue remodelling due to the OA disease process) is
statistically signiﬁcantly increased in participants with mild OA
compared to those without radiographic OA. As such these obser-
vations still support that AGE accumulation may be one of the
molecular mechanisms by which aging leads to OA. However,
relations are weak and age is still a confounder.
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